These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 19368208)

  • 41. Pathogenic prion protein is degraded by a manganese oxide mineral found in soils.
    Russo F; Johnson CJ; Johnson CJ; McKenzie D; Aiken JM; Pedersen JA
    J Gen Virol; 2009 Jan; 90(Pt 1):275-80. PubMed ID: 19088299
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Novel aspects of prions, their receptor molecules, and innovative approaches for TSE therapy.
    Vana K; Zuber C; Nikles D; Weiss S
    Cell Mol Neurobiol; 2007 Feb; 27(1):107-28. PubMed ID: 17151946
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prion-like disorders and Transmissible Spongiform Encephalopathies: An overview of the mechanistic features that are shared by the various disease-related misfolded proteins.
    Eraña H; Venegas V; Moreno J; Castilla J
    Biochem Biophys Res Commun; 2017 Feb; 483(4):1125-1136. PubMed ID: 27590581
    [TBL] [Abstract][Full Text] [Related]  

  • 44. PrP genetics in ruminant transmissible spongiform encephalopathies.
    Goldmann W
    Vet Res; 2008; 39(4):30. PubMed ID: 18284908
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Experimental approaches to TSE prevention via inhibition of prion formation.
    Politopoulou G
    Protein Pept Lett; 2004 Jun; 11(3):249-55. PubMed ID: 15182226
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Experimental approaches to the interaction of the prion protein with nucleic acids and glycosaminoglycans: Modulators of the pathogenic conversion.
    Silva JL; Vieira TC; Gomes MP; Rangel LP; Scapin SM; Cordeiro Y
    Methods; 2011 Mar; 53(3):306-17. PubMed ID: 21145399
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Detection of PrP in extraneural tissues.
    Brown KL; Ritchie DL; McBride PA; Bruce ME
    Microsc Res Tech; 2000 Jul; 50(1):40-5. PubMed ID: 10871547
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Metals in obex and retropharyngeal lymph nodes of Illinois white-tailed deer and their variations associated with CWD status.
    Rivera NA; Novakofski J; Weng HY; Kelly A; Satterthwaite-Phillips D; Ruiz MO; Mateus-Pinilla N
    Prion; 2015; 9(1):48-58. PubMed ID: 25695915
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The pathological prion protein forms ionic conductance in lipid bilayer.
    Paulis D; Maras B; Schininà ME; di Francesco L; Principe S; Galeno R; Abdel-Haq H; Cardone F; Florio T; Pocchiari M; Mazzanti M
    Neurochem Int; 2011 Aug; 59(2):168-74. PubMed ID: 21683106
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Safety evaluation for a biodiesel process using prion-contaminated animal fat as a source.
    Seidel B; Alm M; Peters R; Kördel W; Schäffer A
    Environ Sci Pollut Res Int; 2006 Mar; 13(2):125-30. PubMed ID: 16612902
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Unconventional transmissible agents or prions].
    Dormont D
    Presse Med; 1997 Mar; 26(9):425-30. PubMed ID: 9137406
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prion diseases and their biochemical mechanisms.
    Cobb NJ; Surewicz WK
    Biochemistry; 2009 Mar; 48(12):2574-85. PubMed ID: 19239250
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Styrylbenzoazole derivatives for imaging of prion plaques and treatment of transmissible spongiform encephalopathies.
    Ishikawa K; Kudo Y; Nishida N; Suemoto T; Sawada T; Iwaki T; Doh-ura K
    J Neurochem; 2006 Oct; 99(1):198-205. PubMed ID: 16987247
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Insights into Mechanisms of Transmission and Pathogenesis from Transgenic Mouse Models of Prion Diseases.
    Moreno JA; Telling GC
    Methods Mol Biol; 2017; 1658():219-252. PubMed ID: 28861793
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Temperature influences the interaction of ruminant PrP (TSE) with soil.
    Maddison BC; Owen JP; Taema MM; Shaw G; Gough KC
    Prion; 2012 Jul; 6(3):302-8. PubMed ID: 22561162
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prion: toxic or infectious agent?
    Rico A
    Med Hypotheses; 2003 Feb; 60(2):209-14. PubMed ID: 12606237
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Generation of genuine prion infectivity by serial PMCA.
    Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
    Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Peroxymonosulfate Rapidly Inactivates the Disease-Associated Prion Protein.
    Chesney AR; Booth CJ; Lietz CB; Li L; Pedersen JA
    Environ Sci Technol; 2016 Jul; 50(13):7095-105. PubMed ID: 27247993
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Species-barrier phenomenon in prion transmissibility from a viewpoint of protein science.
    Hagiwara K; Hara H; Hanada K
    J Biochem; 2013 Feb; 153(2):139-45. PubMed ID: 23284000
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prion Strains Differ in Susceptibility to Photodynamic Oxidation.
    Kostelanska M; Holada K
    Molecules; 2022 Jan; 27(3):. PubMed ID: 35163872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.